Zulekha Hospital Sharjah is a top hospital for Malignant Mesothelioma Treatment, offering multidisciplinary cancer care supported by experienced oncologists, surgeons, and modern medical infrastructure. Established in 1992, the JCI hospital is situated in Sharjah, United Arab Emirates and has 185 beds.

Malignant Mesothelioma is an uncommon and aggressive cancer that most commonly develops in the lining of the lungs, known as pleural mesothelioma, but can also affect the lining of the abdomen and other areas. Treatment is selected according to the cancer's location, stage, and overall health of the patient. Depending on the clinical situation, treatment may include surgery, chemotherapy, immunotherapy, radiation therapy, or supportive care. Regular monitoring helps assess treatment response and manage symptoms.